Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma

BACKGROUND: Apatinib, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, has shown promising therapeutic effect for hepatocellular carcinoma (HCC). This prospective clinical study was implemented to evaluate the efficacy and safety of apatinib combined with transarterial chemoembol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Gu, Huiying, Li, Jing, You, Nan, Wu, Ke, Wang, Zheng, Wang, Liang, Zhu, Yinan, Liu, Qinqin, Peng, Xuehui, Zheng, Lu
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812192/
https://ncbi.nlm.nih.gov/pubmed/33490189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-7244
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados